Author:
Feng F Y,Varambally S,Tomlins S A,Chun P Y,Lopez C A,Li X,Davis M A,Chinnaiyan A M,Lawrence T S,Nyati M K
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference40 articles.
1. Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B et al. (1991). A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 9: 491–498.
2. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH et al. (2002). Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62: 7350–7356.
3. Baselga J, Trigo JM, Bourhis J, Tortochaux J, Cortes-Funes H, Hitt R et al. (2005). Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 23: 5568–5577.
4. Benhar M, Engelberg D, Levitzki A . (2002). Cisplatin-induced activation of the EGF receptor. Oncogene 21: 8723–8731.
5. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al. (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354: 567–578.
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献